Zobrazeno 1 - 3
of 3
pro vyhledávání: '"José Gorgonio Acuña Ochoa"'
Autor:
Rosario López-Rodríguez, Aida Ferreiro-Iglesias, Aurea Lima, Miguel Bernardes, Andrzej Pawlik, Agnieszka Paradowska-Gorycka, Jerzy Świerkot, Ryszard Slezak, Vita Dolžan, Isidoro González-Álvaro, Javier Narváez, Rafael Cáliz, Eva Pérez-Pampín, Antonio Mera-Varela, Laura Vidal-Bralo, José Gorgonio Acuña Ochoa, Carmen Conde, Juan J. Gómez-Reino, Antonio González
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-8 (2018)
Abstract About 70 genetic studies have already addressed the need of biomarkers to predict the response of patients with rheumatoid arthritis (RA) to methotrexate (MTX) treatment. However, no genetic biomarker has yet been sufficiently validated. Her
Externí odkaz:
https://doaj.org/article/2feae63c8b2a4e138135868ba1a187e3
Autor:
Carmen Conde, Antonio Gonzalez, Andrzej Pawlik, Rafael Cáliz, Agnieszka Paradowska-Gorycka, Isidoro González-Álvaro, Aida Ferreiro-Iglesias, Miguel Bernardes, José Gorgonio Acuña Ochoa, Jerzy Świerkot, Javier Narváez, Ryszard Slezak, Juan J. Gomez-Reino, Laura Vidal-Bralo, Vita Dolžan, Antonio Mera-Varela, Eva Perez-Pampin, Rosario López-Rodríguez, Aurea Lima
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Recercat. Dipósit de la Recerca de Catalunya
instname
Scientific Reports, Vol 8, Iss 1, Pp 1-8 (2018)
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Scientific Reports
Universidad de Barcelona
Recercat. Dipósit de la Recerca de Catalunya
instname
Scientific Reports, Vol 8, Iss 1, Pp 1-8 (2018)
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Scientific Reports
About 70 genetic studies have already addressed the need of biomarkers to predict the response of patients with rheumatoid arthritis (RA) to methotrexate (MTX) treatment. However, no genetic biomarker has yet been sufficiently validated. Here, we aim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fb3332711b957fe32b07aa32b3039f4
http://hdl.handle.net/2445/123924
http://hdl.handle.net/2445/123924
Autor:
Laura Vidal-Bralo, Aida Ferreiro-Iglesias, Agnieszka Paradowska‑Gorycka, Miguel Bernardes, Javier Narváez, Antonio Gonzalez, Carmen Conde, Andrzej Pawlik, José Gorgonio Acuña-Ochoa, Eva Perez-Pampin, Rosario López-Rodríguez, Aurea Lima, Jerzy Świerkot, Ryszard Slezak, Antonio Mera-Varela, Isidoro González-Álvaro
Publikováno v:
The pharmacogenomics journal. 18(4)
Variability of response to treatment hinders successful management of rheumatoid arthritis (RA). Consequently, a clinical pharmacogenetics model for predicting response to methotrexate (CP-MTX) has been previously proposed that includes four clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca3b68f885e182525c47e3a0a467d51a
https://pubmed.ncbi.nlm.nih.gov/29520081
https://pubmed.ncbi.nlm.nih.gov/29520081